Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

LiO-AD: Lithium Orotate in Alzheimers Disease Feasibility, Biomarker Engagement, and Clinical Response

NCT07459959 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.

NCT NCT07459959
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07459959 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
LiO-AD: Lithium Orotate in Alzheimers Disease Feasibility, Biomarker Engagement, and Clinical Response
Lead sponsor
Johns Hopkins University
Phase
Phase 1/2
Overall status
Not yet recruiting
Start date
December 1, 2026
Completion date
August 31, 2029
Enrollment
40 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer s disease